Cancer Cell International

Article	Citations
Development of dendritic cell loaded MAGE-A2 long peptide; a potential target for tumor-specific T cell-mediated prostate cancer immunotherapy	308
miR-455/GREM1 axis promotes colorectal cancer progression and liver metastasis by affecting PI3K/AKT pathway and inducing M2 macrophage polarization	306
EBP1 promotes the malignant biological behaviors of kidney renal clear cell carcinoma through activation of p38/HIF-1α signaling pathway	260
Construction of the bromodomain-containing protein-associated prognostic model in triple-negative breast cancer	195
Clinical relevance of macromolecular complexes involving integrins, potassium and sodium ion channels and the sodium/proton antiporter in human breast cancer	188
Intracellular and extracellular factors of colorectal cancer liver metastasis: a pivotal perplex to be fully elucidated	155
Doxorubicin loaded exosomes inhibit cancer-associated fibroblasts growth: in vitro and in vivo study	147
Modifying oncolytic virotherapy to overcome the barrier of the hypoxic tumor microenvironment. Where do we stand?	115
Triple-positive breast cancer: navigating heterogeneity and advancing multimodal therapies for improving patient outcomes	110
The collagen-modifying enzyme GLT25D1 is a prognostic indicator related to immunosuppression and malignant phenotypes in hepatocellular carcinoma	106
Integrating spatial and single-cell transcriptomes reveals the role of COL1A2(+) MMP1(+/-) cancer-associated fibroblasts in ER-positive breast cancer	104
RGS proteins and their roles in cancer: friend or foe?	102
Silencing of histone deacetylase 3 suppresses the development of esophageal squamous cell carcinoma through regulation of miR-494-mediated TGIF1	93
Overexpression of POLA2 in hepatocellular carcinoma is involved in immune infiltration and predicts a poor prognosis	91
NY-ESO-1-specific T cell receptor-engineered T cells and Tranilast, a TRPV2 antagonist bivalent treatment enhances the killing of esophageal cancer: a dual-targeted cancer therapeutic route	87
UBTF facilitates melanoma progression via modulating MEK1/2-ERK1/2 signalling pathways by promoting GIT1 transcription	81
NEK7 promotes gastric cancer progression as a cell proliferation regulator	80
PD-L1 intrinsically promotes the proliferation of breast cancer cells through the SKP2-p27/p21 axis	72
Mesenchymal stem cells in cancer progression and anticancer therapeutic resistance	72
Local radiotherapy for murine breast cancer increases risk of metastasis by promoting the recruitment of M-MDSCs in lung	71
The novel oncogenic factor TET3 combines with AHR to promote thyroid cancer lymphangiogenesis via the HIF-1α/VEGF signaling pathway	69
Molecular mechanism of circRNAs in drug resistance in renal cell carcinoma	68
KCNN4 may weaken anti-tumor immune response via raising Tregs and diminishing resting mast cells in clear cell renal cell carcinoma	68
Retraction Note to: miR-484 suppresses proliferation and epithelial–mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells	67
Retraction Note to: Circ_0008035 contributes to cell proliferation and inhibits apoptosis and ferroptosis in gastric cancer via miR-599/EIF4A1 axis	65

Retraction Note: Circ_002117 binds to microRNA-370 and promotes endoplasmic reticulum stress-induced apoptosis in gastric cancer	64
Multi-omics analysis reveals that neutrophil extracellular traps related gene TIMP1 promotes CRC progression and influences ferroptosis	61
Epigallocatechin-3-gallate and cancer: focus on the role of microRNAs	58
Clinical usefulness and acceleratory effect of macrophage inhibitory cytokine-1 on biliary tract cancer: an experimental biomarker analysis	58
Targeting of 3D oral cancer spheroids by αVβ6 integrin using near-infrared peptide-conjugated IRDye 680	56
Hypoxia-responsive circular RNA circAAGAB reduces breast cancer malignancy by activating p38 MAPK and sponging miR-378 h	56
Antioxidants-related nuclear factor erythroid 2-related factor 2 gene variants associated with HBV-related liver disease	56
Integrating bioinformatics and experimental validation to unveil disulfidptosis-related lncRNAs as prognostic biomarker and therapeutic target in hepatocellular carcinoma	54
Altering phosphorylation in cancer through PP2A modifiers	53
Syntaxin6 contributes to hepatocellular carcinoma tumorigenesis via enhancing STAT3 phosphorylation	53
Disclosing a metabolic signature of cisplatin resistance in MDA-MB-231 triple-negative breast cancer cells by NMR metabolomics	52
Chorioallantoic membrane assay revealed the role of TIPARP (2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible poly (ADP-ribose) polymerase) in lung adenocarcinoma-induced angiogenesis	51
Mechanism of lnRNA-ICL involved in lung cancer development in COPD patients through modulating microRNA-19-3p/NKRF/NF-κB axis	50
miR-1908: a microRNA with diverse functions in cancers and non-malignant conditions	50
Overexpression of CYP11A1 recovers cell cycle distribution in renal cell carcinoma Caki-1	49
A novel prognostic signature based on smoking-associated genes for predicting prognosis and immune microenvironment in NSCLC smokers	49
Targeting cholesterol impairs cell invasion of all breast cancer types	49
Circular RNA circ_ARHGEF28 inhibits MST1/2 dimerization to suppress Hippo pathway to induce cisplatin resistance in ovarian cancer	47
Canine diffuse large B-cell lymphoma downregulates the activity of CD8 + T-cells through tumor-derived extracellular vesicles	46
PDGF-BB accelerates TSCC via fibroblast lactates limiting miR-26a-5p and boosting mitophagy	46
Investigating genomic, proteomic, and post-transcriptional regulation profiles in colorectal cancer: a comparative study between primary tumors and associated metastases	46
The development of the occurrence and metastasis of breast cancer by single-cell sequencing	46
Multidrug resistance genes screening of pancreatic ductal adenocarcinoma based on sensitivity profile to chemotherapeutic drugs	45
Pan-cancer analysis of the oncogenic role of discs large homolog associated protein 5 (DLGAP5) in human tumors	45
Development and validation of a nomogram for evaluating the prognosis of immunotherapy plus antiangiogenic therapy in non-small cell lung cancer	45
Targeted intervention of eIF4A1 inhibits EMT and metastasis of pancreatic cancer cells via c-MYC/miR-9 signaling	45
SULF1 regulates malignant progression of colorectal cancer by modulating ARSH via FAK/PI3K/AKT/mTOR signaling	44
BRD4 PROTAC degrader ARV-825 inhibits T-cell acute lymphoblastic leukemia by targeting 'Undruggable' Myc-pathway genes	44
PI3Kδ inhibitor linperlisib combined with gemcitabine and oxaliplatin for relapsed or refractory diffuse large B-cell lymphoma: a multicenter, single-arm phase Ib/II trial	43
Heterogeneous nuclear ribonucleoprotein C promotes non-small cell lung cancer progression by enhancing XB130 mRNA stability and translation	43
Correction: Epidermal growth factor receptor ligands enriched in follicular fluid exosomes promote oncogenesis of fallopian tube epithelial cells	43
Generation, evolution, interfering factors, applications, and challenges of patient-derived xenograft models in immunodeficient mice	43
Establishment and characterization of a new mouse gastric carcinoma cell line, MCC	43
Coordinated activation of DNMT3a and TET2 in cancer stem cell-like cells initiates and sustains drug resistance in hepatocellular carcinoma	42
Integration of mult-omics and nucleotide metabolism reprogramming signature analysis reveals gastric cancer immunological and prognostic features	42
Interactions of melatonin with various signaling pathways: implications for cancer therapy	42
Molecular mechanisms of miR-192 in cancer: a biomarker and therapeutic target	41
miR-199b-3p contributes to acquired resistance to cetuximab in colorectal cancer by targeting CRIM1 via Wnt/β-catenin signaling	41
ZEB1 promotes the immune escape of ovarian cancer through the MCSF-CCL18 axis	41
LncRNA CRNDE promotes hepatoma cell proliferation by regulating the metabolic reprogramming of M2 macrophages via ERK pathway	41
Prognostic and immunological implications of heterogeneous cell death patterns in prostate cancer	41
Inhibition of KIF20A by transcription factor IRF6 affects the progression of renal clear cell carcinoma	40
SLC25A17 inhibits autophagy to promote triple-negative breast cancer tumorigenesis by ROS-mediated JAK2/STAT3 signaling pathway	40
Exosomes from cervical cancer cells facilitate pro-angiogenic endothelial reconditioning through transfer of Hedgehog–GLI signaling components	40
Imperatorin induces autophagy and G0/G1 phase arrest via PTEN-PI3K-AKT-mTOR/p21 signaling pathway in human osteosarcoma cells in vitro and in vivo	39
Mitochondrial transcription elongation factor TEFM promotes malignant progression of gliomas	39
Cuproptosis: a promising new target for breast cancer therapy	39
Clinical usefulness of the lymphocyte-to-monocyte ratio and aggregate index of systemic inflammation in patients with esophageal cancer: a retrospective cohort study	38
Revisiting characteristics of oncogenic extrachromosomal DNA as mobile enhancers on neuroblastoma and glioma cancers	37
Echinacoside exerts anti-tumor activity via the miR-503-3p/TGF-β1/Smad aixs in liver cancer	37

Melanoma biology and treatment: a review of novel regulated cell death-based approaches	37
Smad2/3/4 complex could undergo liquid liquid phase separation and induce apoptosis through TAT in hepatocellular carcinoma	36
Insulin receptor alternative splicing in breast and prostate cancer	36
Regulatory role of Chitinase 3-like 1 gene in papillary thyroid carcinoma proved by integration analyses of single-cell sequencing with cohort and experimental validations	36
LncRNA HCP5 as a potential therapeutic target and prognostic biomarker for various cancers: a meta‑analysis and bioinformatics analysis	36
Platinum-based drugs induce phenotypic alterations in nucleoli and Cajal bodies in prostate cancer cells	36
Mortalin promotes the evolution of androgen-independent prostate cancer through Wnt/β-catenin signaling pathway	36
A novel qualitative signature based on lncRNA pairs for prognosis prediction in hepatocellular carcinoma	36
Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions	36
Establishment of tumor microenvironment-preserving organoid model from patients with intracranial meningioma	36
DNA mismatch repair system regulates the expression of PD-L1 through DNMTs in cervical cancer	35
RETRACTED ARTICLE: LncRNA LBX2-AS1 promotes colorectal cancer progression and 5-fluorouracil resistance	35
Elucidating the role of Pyroptosis in papillary thyroid cancer: prognostic, immunological, and therapeutic perspectives	35
Single cell RNA-seq data and bulk gene profiles reveal a novel signature of disease progression in multiple myeloma	34
A novel immunogenic cell death-related classification indicates the immune landscape and predicts clinical outcome and treatment response in acute myeloid leukemia	34
Neighboring macrophage-induced alteration in the phenotype of colorectal cancer cells in the tumor budding area	33
CMTM3 suppresses chordoma progress through EGFR/STAT3 regulated EMT and TP53 signaling pathway	33
New insight into long non-coding RNAs associated with bone metastasis of breast cancer based on an integrated analysis	33
Uncovering the cellular and omics characteristics of natural killer cells in the bone marrow microenvironment of patients with acute myeloid leukemia	33
Identification of a new gene signature for prognostic evaluation in cervical cancer: based on cuproptosis-associated angiogenesis and multi-omics analysis	32
Iron metabolism: backfire of cancer cell stemness and therapeutic modalities	32
Tumor-matched and unmatched cancer associated fibroblasts exhibit differential effect on proliferation and FMOD and MMP9 gene expression in head and neck squamous cell carcinoma cells when cocultured	32
Retraction Note: Silencing of TRIM11 suppresses the tumorigenicity of chordoma cells through improving the activity of PHLPP1/AKT	32
Spatially resolved visualization of reprogrammed metabolism in hepatocellular carcinoma by mass spectrometry imaging	31
A pan-cancer analysis indicates long noncoding RNA HAND2-AS1 as a potential prognostic, immunomodulatory and therapeutic biomarker in various cancers including colorectal adenocarcinoma	31
The role of alternative pre-mRNA splicing in cancer progression	31
The impact of LncRNA dysregulation on clinicopathology and survival of pancreatic cancer: a systematic review and meta-analysis (PRISMA compliant)	31
Correction to: Expression and prognostic significance of CBX2 in colorectal cancer: database mining for CBX family members in malignancies and vitro analyses	30
LncRNA CTD-3252C9.4 modulates pancreatic cancer cell survival and apoptosis through regulating IFI6 transcription	30
GLP and G9a histone methyltransferases as potential therapeutic targets for lymphoid neoplasms	30
Gastrointestinal cancers, ACE-2/TMPRSS2 expression and susceptibility to COVID-19	30
Identification of HSPG2 as a bladder pro-tumor protein through NID1/AKT signaling	29
Pitavastatin sensitizes the EGFR-TKI associated resistance in lung cancer by inhibiting YAP/AKT/BAD-BCL-2 pathway	29
Retraction Note: Transcription elongation factor A-like 7, regulated by miR-758-3p inhibits the progression of melanoma through decreasing the expression levels of c-Myc and AKT1	29
CCDC88C, an O-GalNAc glycosylation substrate of GALNT6, drives breast cancer metastasis by promoting c-JUN-mediated CEMIP transcription	29
Retraction Note: LINC00115 promotes stemness and inhibits apoptosis of ovarian cancer stem cells by upregulating SOX9 and inhibiting the Wnt/β-catenin pathway through competitively binding to microRNA	29
Current understanding of functional peptides encoded by lncRNA in cancer	29
Correction: 4,5-Dimethoxycanthin-6-one is a novel LSD1 inhibitor that inhibits proliferation of glioblastoma cells and induces apoptosis and pyroptosis	28
The efficacy of immunotherapy in non-small cell lung cancer with KRAS mutation: a systematic review and meta-analysis	28
Lysosomal gene ATP6AP1 promotes doxorubicin resistance via up-regulating autophagic flux in breast cancer	28
Aldo-keto reductase family 1 member B10 prevents esophageal squamous cell carcinoma from reactive carbonyl species-induced cell death and promotes its progression	28
The potential role of collagen type VII in breast cancer proliferation	28
Competing endogenous RNAs network dysregulation in oral cancer: a multifaceted perspective on crosstalk and competition	28
Metformin regulates the proliferation and motility of melanoma cells by modulating the LINC00094/miR-1270 axis	28
Characterization of the biological and transcriptomic landscapes of bone marrow-derived mesenchymal stem cells in patients with multiple myeloma	28
MicroRNAome profiling of breast cancer unveils hsa-miR-5683 as a tumor suppressor microRNA predicting favorable clinical outcome	28
Correction to: SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomas	28
A systematic review of the therapeutic effects of resveratrol in combination with 5-fluorouracil during colorectal cancer treatment: with a special focus on the oxidant, apoptotic, and anti-inflammato	27
Mechanisms of miR-3189-3p-mediated inhibition of c-MYC translation in triple negative breast cancer	27
Combating drug resistance in acute myeloid leukaemia by drug rotations: the effects of quizartinib and pexidartinib	27
Mass spectrometry imaging in gynecological cancers: the best is yet to come	27
Retraction Note to: LncRNA SNHG12 regulates the radiosensitivity of cervical cancer through the miR-148a/CDK1 pathway	27
Prognostic value of maximum standard uptake value, metabolic tumour volume, and total lesion glycolysis of 18F-FDG PET/CT in patients with malignant pleural mesothelioma: a systematic review and meta-	27
Exosome-based strategies for diagnosis and therapy of glioma cancer	27
Pharmacological targeting transient receptor potential canonical channel 6 modulates biological behaviors for cervical cancer HeLa and SiHA cell	27
Multiomics surface receptor profiling of the NCI-60 tumor cell panel uncovers novel theranostics for cancer immunotherapy	27
Integrative analysis identifies CXCL11 as an immune-related prognostic biomarker correlated with cell proliferation and immune infiltration in multiple myeloma microenvironment	27
The regulation of autophagy by the miR-199a-5p/p62 axis was a potential mechanism of small cell lung cancer cisplatin resistance	27
Integrated analysis to identify the AC005154.6/hsa-miR-29c-3p/CCNL2 axis as a novel prognostic biomarker associated with immune infiltration in prostate cancer	27
Pancancer landscape analysis of the thymosin family identified TMSB10 as a potential prognostic biomarker and immunotherapy target in glioma	27
Down-regulated FST expression is involved in the poor prognosis of triple-negative breast cancer	26
Transition of amyloid/mutant p53 from tumor suppressor to an oncogene and therapeutic approaches to ameliorate metastasis and cancer stemness	26
FZD2 promotes TGF-β-induced epithelial-to-mesenchymal transition in breast cancer via activating notch signaling pathway	26
An antisense amido-bridged nucleic acid gapmer oligonucleotide targeting SRRM4 alters REST splicing and exhibits anti-tumor effects in small cell lung cancer and prostate cancer cells	26
Induction of oxidative DNA damage, cell cycle arrest and p53 mediated apoptosis by calcium titanate nanoparticles in MCF-7 breast cancer cells	26
Molecular subtypes based on cuproptosis-related genes and tumor microenvironment infiltration characterization in ovarian cancer	26
Correction to: The role of JMJD6/U2AF65/AR-V7 axis in castration-resistant prostate cancer progression	25
Exploring the relationship between autophagy and Gefitinib resistance in NSCLC by silencing PDLIM5 using ultrasound-targeted microbubble destruction technology	25
circ-PTK2 (hsa_circ_0008305) regulates the pathogenic processes of ovarian cancer via miR-639 and FOXC1 regulatory cascade	25
Correction to: CTLA4 has a profound impact on the landscape of tumor-infiltrating lymphocytes with a high prognosis value in clear cell renal cell carcinoma (ccRCC)	25
SNHG18 inhibits bladder cancer cell proliferation by increasing p21 transcription through destabilizing c-Myc protein	25
Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma	25
Clinical significance of genetic profiling based on different anatomic sites in patients with mucosal melanoma who received or did not receive immune checkpoint inhibitors	25
GNG5 is a novel oncogene associated with cell migration, proliferation, and poor prognosis in glioma	25
Upregulation of ARNTL2 is associated with poor survival and immune infiltration in clear cell renal cell carcinoma	25
Using dynamic cell communication improves treatment strategies of breast cancer	25
Overexpression of DDIT4 and TPTEP1 are associated with metastasis and advanced stages in colorectal cancer patients: a study utilizing bioinformatics prediction and experimental validation	25
Imaging the metabolic reprograming of fatty acid synthesis pathway enables new diagnostic and therapeutic opportunity for breast cancer	24
CircFAM13B promotes the proliferation of hepatocellular carcinoma by sponging miR-212, upregulating E2F5 expression and activating the P53 pathway	24
In silico analysis of prognostic and diagnostic significance of target genes from prostate cancer cell lines derived exomicroRNAs	24

Identification and validation of eight lysosomes-related genes signatures and correlation with immune cell infiltration in lung adenocarcinoma	24
STAT3 pathway as a molecular target for resveratrol in breast cancer treatment	24
Correction to: Exosomes from tamoxifen-resistant breast cancer cells transmit drug resistance partly by delivering miR-9-5p	24
ALKBH5-mediated CHAC1 depletion promotes malignant progression and decreases cisplatin-induced oxidative stress in gastric cancer	24
Correction to: Synergism between the phosphatidylinositol 3-kinase p110β isoform inhibitor AZD6482 and the mixed lineage kinase 3 inhibitor URMC-099 on the blockade of glioblastoma cell motility and f	24
Anterior gradient 2 induces resistance to sorafenib via endoplasmic reticulum stress regulation in hepatocellular carcinoma	24
Correction to: Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma	24
CircFBXL5 promotes the 5-FU resistance of breast cancer via modulating miR-216b/HMGA2 axis	24
Relationship between PD-L1 expression, CD8+ T-cell infiltration and prognosis in intrahepatic cholangiocarcinoma patients	24
Holothurian triterpene glycoside cucumarioside A2-2 induces macrophages activation and polarization in cancer immunotherapy	24
RNA sequencing analysis reveals the competing endogenous RNAs interplay in resected hepatocellular carcinoma patients who received interferon-alpha therapy	24
MINDY1 promotes bladder cancer progression by stabilizing YAP	24
The oncogenic role of HIF-1α/miR-182-5p/ZFP36L1 signaling pathway in nasopharyngeal carcinoma	24
AP4M1 as a prognostic biomarker associated with cell proliferation, migration and immune regulation in hepatocellular carcinoma	24
Dysregulation of the miR-30a/BiP axis by cigarette smoking accelerates oral cancer progression	23
Identification of methylation-driven genes prognosis signature and immune microenvironment in uterus corpus endometrial cancer	23
Integrative analysis of the ST6GALNAC family identifies GATA2-upregulated ST6GALNAC5 as an adverse prognostic biomarker promoting prostate cancer cell invasion	23
Long non-coding RNA HEIH: a novel tumor activator in multiple cancers	23
LncRNA ASAP1-IT1 enhances cancer cell stemness via regulating miR-509-3p/YAP1 axis in NSCLC	23
NF-kB-dependent activation of STAT3 by H. pylori is suppressed by TFF1	23
A review on the biological roles of LncRNA PTCSC3 in cancerous and non-cancerous disorders	23
Chitosan as possible inhibitory agents and delivery systems in leukemia	23
Clinical M2 macrophages-related genes to aid therapy in pancreatic ductal adenocarcinoma	23
Role of long non-coding RNAs in metabolic reprogramming of gastrointestinal cancer cells	23
CircADARB1 serves as a new biomarker in natural killer T-cell lymphoma and a potential regulator of p-Stat3	23
RNA m6A methylation regulators in ovarian cancer	23
EFNA3 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with lung adenocarcinoma	23
miR-30b-5p inhibits proliferation, invasion, and migration of papillary thyroid cancer by targeting GALNT7 via the EGFR/PI3K/AKT pathway	22
Exosomal transfer of miR-769-5p promotes osteosarcoma proliferation and metastasis by targeting DUSP16	22
The prognosis biomarkers based on m6A-related lncRNAs for myeloid leukemia patients	22
Comprehensive analysis of N6-methyladenosine regulators with the tumor immune landscape and correlation between the insulin-like growth factor 2 mRNA-binding protein 3 and programmed death ligand 1 in	22
STK25 enhances hepatocellular carcinoma progression through the STRN/AMPK/ACC1 pathway	22
hsa_circ_0000231 Promotes colorectal cancer cell growth through upregulation of CCND2 by IGF2BP3/miR-375 dual pathway	22
Prognostic role of METTL1 in glioma	22
Aloperine inhibits the progression of non-small-cell lung cancer through the PI3K/Akt signaling pathway	22
AGAP2-AS1 as a prognostic biomarker in low-risk clear cell renal cell carcinoma patients with progressing disease	22
miR-30a targets STOX2 to increase cell proliferation and metastasis in hydatidiform moles via ERK, AKT, and P38 signaling pathways	22
miR-133a targets YES1 to reduce cisplatin resistance in ovarian cancer by regulating cell autophagy	22
Concern about: Echinacoside exerts anti-tumor activity via the miR-503-3p/TGF-β1/Smad aixs in liver cancer	22
Long non-coding RNA CRNDE exacerbates NPC advancement mediated by the miR-545-5p/CCND2 axis	22
The Prognostic value of the Fibrinogen to pre-albumin ratio in malignant tumors of the digestive system: a systematic review and meta-analysis	22
Overexpression of CBS/H2S inhibits proliferation and metastasis of colon cancer cells through downregulation of CD44	22
Correction to: Exosomal lncRNA SNHG10 derived from colorectal cancer cells suppresses natural killer cell cytotoxicity by upregulating INHBC	22
Nanotechnology-based advances in the efficient delivery of melatonin	22
Impact of cumulative cisplatin dose in childhood nasopharyngeal carcinoma based on neoadjuvant chemotherapy response in the intensity-modulated radiotherapy era: a real-world study	22
Biological and therapeutic implications of RKIP in Gastrointestinal Stromal Tumor (GIST): an integrated transcriptomic and proteomic analysis	21
Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression	21
Signature construction and molecular subtype identification based on liver-specific genes for prediction of prognosis, immune activity, and anti-cancer drug sensitivity in hepatocellular carcinoma	21
Extracellular vesicle-mediated delivery of miR-766-3p from bone marrow stromal cells as a therapeutic strategy against colorectal cancer	21
Non-coding RNAs as potential targets in metformin therapy for cancer	21
Potential role of P4HB in the tumor microenvironment and its clinical prognostic value: a comprehensive pan-cancer analysis and experimental validation with a focus on KIRC	21
The effects of ARID1A mutation in gastric cancer and its significance for treatment	21
Curcumin attenuates smoking and drinking activated NF-κB/IL-6 inflammatory signaling axis in cervical cancer	21
Microbial and molecular differences according to the location of head and neck cancers	21
Molecular mechanisms of microRNA-216a during tumor progression	21
Telomerase related molecular subtype and risk model reveal immune activity and evaluate prognosis and immunotherapy response in prostate cancer	21
Urinary biomarkers for hepatocellular carcinoma: current knowledge for clinicians	21
PTH2R is related to cell proliferation and migration in ovarian cancer: a multi-omics analysis of bioinformatics and experiments	21
Molecular mechanism underlying the apoptotic modulation by ethanol extract of Pseudolarix kaempferi in mucoepidermoid carcinoma of the salivary glands	21
Decoding contextual crosstalk: revealing distinct interactions between non-coding RNAs and unfolded protein response in breast cancer	21
Glucose metabolism in glioma: an emerging sight with ncRNAs	21
Deciphering the prognostic features of bladder cancer through gemcitabine resistance and immune-related gene analysis and identifying potential small molecular drug PIK-75	21
Myeloid cell leukemia-1 expression in cancers of the oral cavity: a scoping review	21
The addition of arginine deiminase potentiates Mithramycin A-induced cell death in patient-derived glioblastoma cells via ATF4 and cytochrome C	21
Analysis of immune status and prognostic model incorporating lactic acid metabolism-associated genes	21
TMEM71 is crucial for cell proliferation in lower-grade glioma and is linked to unfavorable prognosis	21
Exercise and colorectal cancer: prevention and molecular mechanisms	21
Nectin-4 promotes osteosarcoma progression and metastasis through activating PI3K/AKT/NF-κB signaling by down-regulation of miR-520c-3p	21
Long noncoding RNA SNHG4: a novel target in human diseases	21
Exploring the role of the disulfidptosis-related gene SLC7A11 in adrenocortical carcinoma: implications for prognosis, immune infiltration, and therapeutic strategies	21
DHRS4-AS1 regulate gastric cancer apoptosis and cell proliferation by destabilizing DHX9 and inhibited the association between DHX9 and ILF3	20
LncRNA MONC suppresses the malignant phenotype of Endometrial Cancer Stem Cells and Endometrial Carcinoma Cells by regulating the MiR-636/GLCE axis	20
Targeting hyaluronic acid synthase-3 (HAS3) for the treatment of advanced renal cell carcinoma	20
Correction to: Short‑term starvation synergistically enhances cytotoxicity of Niraparib via Akt/mTOR signaling pathway in ovarian cancer therapy	20
WD40 repeat 43 mediates cell survival, proliferation, migration and invasion via vimentin in colorectal cancer	20
A three-snoRNA signature: SNORD15A, SNORD35B and SNORD60 as novel biomarker for renal cell carcinoma	20
MiRNA-related metastasis in oral cancer: moving and shaking	20
Correction to: B7-H3 promotes aggression and invasion of hepatocellular carcinoma by targeting epithelial-to-mesenchymal transition via JAK2/STAT3/Slug signaling pathway	20
LncRNA FOXD1-AS1 regulates pancreatic cancer stem cell properties and 5-FU resistance by regulating the miR-570-3p/SPP1 axis as a ceRNA	20
Construction of a CCL20-centered circadian-signature based prognostic model in cervical cancer	20
Correction: FOXM1-induced TYMS upregulation promotes the progression of hepatocellular carcinoma	20
HOTAIR in cancer: diagnostic, prognostic, and therapeutic perspectives	20
ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors	20
Iron-sulphur cluster biogenesis factor LYRM4 is a novel prognostic biomarker associated with immune infiltrates in hepatocellular carcinoma	20
Identification of autophagy-related risk signatures for the prognosis, diagnosis, and targeted therapy in cervical cancer	20
Construction of feature selection and efficacy prediction model for transformation therapy of locally advanced pancreatic cancer based on CT, 18F-FDG PET/CT, DNA mutation, and CA199	20
Correction to: CCR9 initiates epithelial–mesenchymal transition by activating Wnt/β-catenin pathways to promote osteosarcoma metastasis	20
How metformin affects various malignancies by means of microRNAs: a brief review	20
The MYBL2–CCL2 axis promotes tumor progression and resistance to anti-PD-1 therapy in ovarian cancer by inducing immunosuppressive macrophages	20
Exosomal circRNA RHOT1 promotes breast cancer progression by targeting miR-204-5p/ PRMT5 axis	20
Knockdown of PGM1 enhances anticancer effects of orlistat in gastric cancer under glucose deprivation	20
Helicobacter pylori-induced fibroblast-derived Serpin E1 promotes gastric cancer growth and peritoneal dissemination through p38 MAPK/VEGFA-mediated angiogenesis	19
SHC4 promotes tumor proliferation and metastasis by activating STAT3 signaling in hepatocellular carcinoma	19
The pathogenic roles of lncRNA-Taurine upregulated 1 (TUG1) in colorectal cancer	19
Combinatorial targeting of menin and the histone methyltransferase DOT1L as a novel therapeutic strategy for treatment of chemotherapy-resistant ovarian cancer	19